Cervical cancer has emerged as the fastest-growing cancer in Canada, prompting urgent calls from medical professionals for the federal government to intensify its efforts to combat this public health crisis. At a press conference held in Ottawa on Wednesday, the Society of Gynecologic Oncology of Canada highlighted the alarming statistics surrounding cervical cancer diagnoses and deaths, despite the government’s commitment to eliminate the disease by 2040.
The Alarming Rise in Cervical Cancer Cases
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, described the situation as a “silent national health crisis.” She revealed that in 2025, approximately 1,650 Canadians were expected to be diagnosed with cervical cancer, with 430 anticipated deaths from the disease—deaths that Dr. Salvador deemed “avoidable.”
The reliance on traditional Pap tests for screening has proven insufficient, and vaccination rates for the human papillomavirus (HPV), a major contributor to cervical cancer, have stagnated. Currently, only 64 per cent of eligible Canadians have completed the HPV vaccination series, a figure Dr. Salvador criticises as inadequate for achieving the goal of elimination.
A Call for Policy Reform
Dr. Salvador emphasised the need for a “national shift” in cervical cancer screening practices, advocating for the immediate adoption of HPV DNA testing and the implementation of self-collection kits. These kits would allow individuals to collect samples at home, thus removing barriers related to access and historical trauma, particularly for those in rural and underserved communities.
“The health gender gap has persisted for years, disproportionately affecting rural, Indigenous, and marginalised populations,” Dr. Salvador stated. “By facilitating at-home testing, we can address the systemic issues that have led to these disparities.”
The Impact on Indigenous Communities
Dr. Sarah Kean, provincial lead for cervical cancer in Manitoba, elaborated on the heightened risks faced by Indigenous women, who are diagnosed more frequently and at later stages of the disease. “This is not a biological issue,” Dr. Kean asserted. “It stems from significant barriers in accessing screening resources, geographic isolation, and persistent systemic racism within healthcare systems.”
The pressing need for comprehensive and accessible HPV screening is clear. Dr. Kean urged for federal legislation to support universal access to primary HPV testing across all provinces, asserting that improvements must extend beyond mere updates to guidelines.
Economic Consequences and Future Outlook
The financial burden of cervical cancer on the Canadian healthcare system is substantial. Dr. Salvador noted that the cost of treating cervical cancer was projected to reach £132 million in 2024, while screening eligible Canadians could amount to £106 million over five years. These figures underscore the urgent need for proactive measures to stem the tide of this preventable disease.
As the World Health Organization’s global strategy to eliminate cervical cancer continues to evolve, Canadian experts stress that the country’s progress appears to be stalling. A report by the Canadian Cancer Society indicates a worrying trend: although cervical cancer rates were declining steadily from 1984 to 2005, the annual decrease slowed dramatically from 2005 to 2021.
Why it Matters
The rising incidence of cervical cancer in Canada is a clarion call for immediate and decisive action. As medical professionals advocate for enhanced screening and vaccination practices, it becomes increasingly clear that the health of countless individuals—especially those in vulnerable communities—hangs in the balance. Addressing this crisis is not merely a medical imperative; it is a moral one that demands the attention and resources of the government. With the right policies in place, Canada can move closer to eliminating cervical cancer as a public health problem and ensuring equitable access to care for all.
